26 مايو #efficacy #MENA #pazopanib #real-life experience #safety #second-line #soft tissue sarcoma Safety and efficacy of pazopanib as a second-line treatment and beyond for soft tissue sarcomas: A real-life tertiary-center experience in the MENA region by Dr. Fadi Farhat 0
06 سبتمبر #immunotherapy #Lung Cancer #real-life experience #second-line Lung cancer and immunotherapy: a real-life experience from second-line and beyond by Dr. Fadi Farhat 0